Showing results (141-150 of 190) with videos related to
Sort By:
Pageof 19
Blood|August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.Leukemia Research|March 27, 2013
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129Dan Douer, Lynette N Zickl, Charles A Schiffer, et al.The Journal of Experimental Medicine|December 14, 2011
ETV6 mutations in early immature human T cell leukemiasPieter Van Vlierberghe, Alberto Ambesi-Impiombato, Arianne Perez-Garcia, et al.American Journal of Hematology|June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experienceChezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.Nature Medicine|February 28, 2012
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALLGiusy Della Gatta, Teresa Palomero, Arianne Perez-Garcia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2024
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810Leonard J Appleman, Se Eun Kim, Wayne B Harris, et al.Cancer Discovery|October 29, 2021
Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic LeukemiaMarissa Rashkovan, Robert Albero, Francesca Gianni, et al.Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cellsStephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.Oncology|August 25, 2010
Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access programRonald M Bukowski, Walter M Stadler, David F McDermott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinomaDavid F McDermott, Meredith M Regan, Joseph I Clark, et al.Pageof 19